EirGenix
Taipei · Founded 2012
About EirGenix
EirGenix Inc., health is important for all people. Under this belief, EirGenix established two business units to achieve the goal. One is contract development and manufacturing operation unit where EirGenix helps clients to manufacture their biologics; the other is the product development operation unit where they hope to fully apply their team's experience and knowledge on biologics from biosimilars, biobetters to new drugs. EirGenix's goal is that every patient can afford high-quality biopharmaceutical drugs.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $179.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2022)
- Ticker: tpe:6589
- Website: http://www.eirgenix.com/
Industries & Categories
Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/eirgenix-154441 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.